|
| Press Releases |
|
 |
|
| Saturday, June 1, 2024 |
|
|
Avance Clinical通过与Julius Clinical合作，在欧洲扩展专门的中枢神经系统、心血管代谢和罕见疾病的CRO服务 |
| 澳大利亚和北美市场领先的获奖CRO公司Avance Clinical与Julius Clinical签署了一份谅解备忘录（MOU）。Julius Clinical是一家在中枢神经系统、心血管代谢和罕见疾病领域的专业CRO，在该地区拥有广泛的站点关系。 more info >> |
|
| Friday, May 31, 2024 |
|
|
Avance Clinical Expands Specialist CNS, Cardiometabolic, and Rare Diseases CRO Services in Europe with Julius Clinical |
| Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs has signed a Memorandum of Understanding (MOU) with Julius Clinical, a leading CNS, cardiometabolic, and rare diseases specialist CRO with extensive site relationships in the region. more info >> |
|
| Thursday, May 9, 2024 |
|
|
Avance Clinical, 한국에서 새로운 임상 운영으로 APAC 지역으로 더 확장 |
| Avance Clinical, 은 수상 경력이 있는 호주 및 북미 지역의 생명공학 분야 선도 CRO로서, 2024년 5월 8일부터 10일까지 BIO Korea에 참가하고 한국 서울에서 새로운 임상 운영을 공식적으로 시작할 예정입니다. more info >> |
|
|
Avance Clinical 在亞太地區進一步擴張，韓國新的臨床運營 |
| more info >> |
|
|
Avance Clinical 在亚太地区进一步扩张，韩国新的临床运营 |
| Avance Clinical，这家屡获殊荣的澳大利亚和北美市场领先的生物技术公司CRO，将参加2024年5月8日至10日的韩国生物技术展，并将在韩国首尔正式开展新的临床运营。 more info >> |
|
| Wednesday, May 8, 2024 |
|
|
Avance Clinical Expands Further into APAC with New Clinical Operations in South Korea |
| Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will attend BIO Korea (May 8-10, 2024) and formally open new clinical operations in Seoul, South Korea. more info >> |
|
| Monday, April 22, 2024 |
|
|
Avance Clinical은 4월 23일부터 25일까지 보스턴에서 열리는 세계 고아약 학회에서 임상 우수성을 선보입니다 |
| 바이오테크 기업을 위한 수상 경력을 가진 북미와 호주 시장을 선도하는 CRO인 Avance Clinical은 보스턴에서 열리는 세계 고아약 학회 참석하여 (2024년 4월 23일부터 25일까지) 바이오테크 기업들에게 자신들의 희귀 질환 의약품 개발 전문지식을 공유할 것입니다 (부스 #730). more info >> |
|
| Saturday, April 20, 2024 |
|
|
Avance Clinical 在4月23日至25日波士頓世界孤兒藥物會議上展示臨床突出成績 |
| Avance Clinical，作為备受讚譽的北美和澳大利亞領先生物技術公司的CRO，將出席2024年波士頓 世界孤兒藥物會議（4月23日至25日），與生物技術公司分享他們在罕見疾病藥物開發方面的專業知識（展台號：730）。 more info >> |
|
|
Avance Clinical 在4月23日至25日波士顿世界孤儿药物会议上展示临床突出成绩 |
| Avance Clinical，作为备受赞誉的北美和澳大利亚领先生物技术公司的CRO，将出席2024年波士顿 世界孤儿药物会议（4月23日至25日），与生物技术公司分享他们在罕见疾病药物开发方面的专业知识（展台号：730）。 more info >> |
|
| Friday, April 19, 2024 |
|
|
Avance Clinical Showcases Clinical Excellence at World Orphan Drug Conference in Boston, April 23-25 |
| Avance Clinical, the award-winning North American and Australian market-leading CRO for biotechs, will attend World Orphan Drug Conference in Boston (April 23-25, 2024) to share their rare diseases drug development expertise with biotechs (booth #730). more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
三菱造船と日本製鉄が低圧液化CO₂タンクの新規鋼材と熱処理（PWHT）省略技術を開発
Dec 5, 2025 11:30: JST
|
|
|
LEXUS、バッテリーEVスポーツカーのコンセプトモデル「Lexus LFA Concept」を世界初公開
Dec 5, 2025 11:20: JST
|
|
|
Doubleview Extends High-Grade Domains at Hat: H099 Returns 438m of 0.40% CuEq Including 52m of 1.02% CuEq, Expanding Mineralization Envelope Around Conceptual Pit Vertically and Laterally
Dec 4, 2025 21:59 HKT/SGT
|
|
|
Business of IP Asia (BIP Asia) Forum and Entrepreneur Day open today
Dec 4, 2025 21:00 HKT/SGT
|
|
|
CaoCao Unveils '100 Cities, 100 Billion in 10 Years' Robotaxi Strategy, Officially Launches World's First 'Green Intelligent Mobility Hub'
Dec 4, 2025 21:00 HKT/SGT
|
|
|
曹操出行發佈Robotaxi「十年百城千億」戰略目標 全球首個「綠色智慧通行島」正式啟用
Dec 4, 2025 18:18 HKT/SGT
|
|
|
The Gourmet's Guide: Using Your TravelKon eSIM to Hunt for Japan's Best Ramen, Sushi, and Street Food
Dec 4, 2025 17:45 HKT/SGT
|
|
|
Oman's 10-Year Golden Residency Program Attracts Global Investors Seeking Stability and Long-Term Access
Dec 4, 2025 16:19 HKT/SGT
|
|
|
Spritzer Celebrates Global and Regional Brand Excellence 2025
Dec 4, 2025 12:45 HKT/SGT
|
|
|
Honda、新型「CR-V」の先行予約開始
Dec 4, 2025 11:30: JST
|
|
|
在聯泓格潤「超級工廠」看見綠色材料全鏈路
Dec 4, 2025 09:36 HKT/SGT
|
|
|
在联泓格润"超级工厂" 看见绿色材料全链路
Dec 4, 2025 09:14 HKT/SGT
|
|
|
阿曼十年黃金居留計劃吸引全球投資者尋求穩定與長期通達
Dec 4, 2025 08:00 HKT/SGT
|
|
|
阿曼十年黄金居留计划吸引全球投资者寻求稳定与长期准入
Dec 4, 2025 08:00 HKT/SGT
|
|
|
The 26th Hong Kong Forum marks successful completion
Dec 3, 2025 22:44: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
